je.st
news
Abbvie Projects $3B Sales For HCV Cocktail, But Shares Fall 3%
2015-02-02 19:46:47| Biotech - Topix.net
Abbvie reported solid Q4 earnings last week, despite one-time expenses for fees related to backing out of acquiring Shire Plc. Management did nothing to assuage investors that its HCV regimen was on pace to achieve its $2 billion 2015 revenue target.
Tags: sales
fall
projects
shares
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||